ANCAs against proteinase 3 (PR3) (PR3-ANCA) or myeloperoxidase (MPO) (MPO-ANCA) are found in over 90% of patients with active disease, and these ANCAs are implicated in the pathogenesis of AAV. Here, PRTN3 is linked to anti-neutrophil cytoplasmic antibody-associated vasculitis.